Healthy H1 FY20/21 performance; momentum to sustain during Q3 FY20/21
18/11/20 -"Experian performed strongly in Q2 FY20/21 (+5% yoy organic revenue; at top-end of management’s guidance), on the back of the sustained robust momentum in the US mortgage activity and consumer ..."
Pages
52
Language
English
Published on
18/11/20
You may also be interested by these reports :
11/03/26
The adjustment of the target price reflects the update of our model (see comments on EPS and NAV). The company remains solid and achieved its ...
09/03/26
We remain positive on Bilfinger, as its business model is light on fixed assets, and more than 80% of revenue is recurring, which should provide a ...
05/03/26
Rentokil Initial reported H2 results in line with market expectations for sales, EBIT, and EPS. North America continues to show signs of ...
04/03/26
Bilfinger’s full-year results for 2025 exceeded expectations in ways that merit closer examination. Free cash flow surged 75% to €330 million, the ...